GPR52 MODULATOR COMPOUNDS

The disclosures herein relate to novel compounds of Formula (1a) or (1b) or a salt thereof, wherein R1, R2, R3, R4, R8, R9 and R10 are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of disorders associated with GPR52 receptors. L'invention...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	O'BRIEN, Michael Alistair, WATSON, Stephen Paul, SWAIN, Nigel Alan
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The disclosures herein relate to novel compounds of Formula (1a) or (1b) or a salt thereof, wherein R1, R2, R3, R4, R8, R9 and R10 are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of disorders associated with GPR52 receptors. L'invention concerne de nouveaux composés représentés par la formule (1a) ou (1b) ou un sel de celui-ci, dans laquelle R1, R2, R3, R4, R8, R9 et R10 sont tels que définis dans la description, et leur utilisation pour traiter, prévenir, atténuer, supprimer des troubles associés aux récepteurs GPR52 ou réduire le risque d'apparition de tels troubles.